Expand CLDX Menu
CLDX MENU

Celldex Therapeutics (CLDX) closed at $27.42 on November 20, 2026, down 1.9% from the previous close, on volume of 1,483,527 shares (30-day average 905,084).

Key numbers
  • Last close: $27.42 (November 20, 2026)
  • 52-week range: $22.33 to $45.14
  • Market value: $2.2 billion
  • 30-day implied volatility (IV30): 39.7%
  • Option volume: 573 contracts (67 calls, 506 puts); 30-day average 92

Data as of November 20, 2026.

CLDX Stock Summary and Trading Ideas (Celldex Therapeutics | NASDAQ:CLDX)

Charts for Today's Stock Price and Implied Volatility in Celldex Therapeutics

20-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for CLDX by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Oct 22, 2026 Call Butterfly (Skip Strike) 19-Mar-2738 : 50[2x] : 60 C 240

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days

Trading Statistics

Key Ratios

Celldex Therapeutics (CLDX) Frequently Asked Questions

What does Celldex Therapeutics do?

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

What symbol and exchange does Celldex Therapeutics shares trade?

Celldex Therapeutics trades on the NASDAQ stock market under the symbol CLDX.

What is Celldex Therapeutics stock price doing today?

As of November 20, 2026, CLDX stock price declined to $27.42 with 1,483,527 million shares trading.

What is Celldex Therapeutics's Beta?

CLDX has a beta of 0.71, meaning it tends to be less sensitive to market movements. CLDX has a correlation of 0.04 to the broad based SPY ETF.

How much is Celldex Therapeutics worth?

CLDX has a market cap of $2.15 billion. This is considered a Mid Cap stock.

How much money does Celldex Therapeutics make?

Last quarter Celldex Therapeutics reported $0 in Revenue and -$.96 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Celldex Therapeutics traded in the last 3 year period?

In the last 3 years, CLDX traded as high as $53.18 and as low as $14.40.

What are the top ETFs holding Celldex Therapeutics?

The top ETF exchange traded funds that CLDX belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWO.

Is Celldex Therapeutics (CLDX) a good investment?

CLDX has outperformed the market in the last year with a return of +9.4%, while the SPY ETF gained +6.9%. However, in the most recent history, CLDX shares have underperformed the stock market with its stock returning -31.3% in the last 3 month period and -8.2% for the last 2 week period, while SPY has returned -9.3% and -6.2%, respectively.

What are the support and resistance levels for Celldex Therapeutics (CLDX)?

CLDX support price is $27.07 and resistance is $28.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLDX shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes